These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 38793043)
41. Pediatric immune-mediated necrotizing myopathy. Wang CH; Liang WC Front Neurol; 2023; 14():1123380. PubMed ID: 37021281 [TBL] [Abstract][Full Text] [Related]
42. Complement-mediated muscle cell lysis: a possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM). Rojana-udomsart A; Mitrpant C; Bundell C; Price L; Luo YB; Fabian V; Wilton SD; Hollingsworth P; Mastaglia FL J Neuroimmunol; 2013 Nov; 264(1-2):65-70. PubMed ID: 24041831 [TBL] [Abstract][Full Text] [Related]
43. Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy. Kruse RL; Albayda J; Vozniak SO; Lawrence CE; Goel R; Lokhandwala PM; Ness PM; Tobian AAR; Bloch EM; Crowe EP J Clin Apher; 2022 Jun; 37(3):253-262. PubMed ID: 35119135 [TBL] [Abstract][Full Text] [Related]
44. Necrotising myopathy associated with anti-signal recognition particle (anti-SRP) antibody. De Souza FHC; Miossi R; Shinjo SK Clin Exp Rheumatol; 2017; 35(5):766-771. PubMed ID: 28281460 [TBL] [Abstract][Full Text] [Related]
45. Anti-signal recognition particle antibody in patients without inflammatory myopathy: a survey of 6180 patients with connective tissue diseases. Hanaoka H; Kaneko Y; Suzuki S; Takada T; Hirakata M; Takeuchi T; Kuwana M Scand J Rheumatol; 2016 Jan; 45(1):36-40. PubMed ID: 26312949 [TBL] [Abstract][Full Text] [Related]
46. Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome. Suzuki S; Hayashi YK; Kuwana M; Tsuburaya R; Suzuki N; Nishino I Arch Neurol; 2012 Jun; 69(6):728-32. PubMed ID: 22332183 [TBL] [Abstract][Full Text] [Related]
47. Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies. Julien S; Challier I; Malleter M; Jouen F; Drouot L; Boyer O Antibodies (Basel); 2024 Feb; 13(1):. PubMed ID: 38390873 [TBL] [Abstract][Full Text] [Related]
48. Alanine transaminase is predominantly increased in the active phase of anti-HMGCR myopathy. Kubota A; Shimizu J; Unuma A; Maeda M; Shirota Y; Kadoya M; Uchio N; Sakiyama Y; Arai N; Shiio Y; Uesaka Y; Hashida H; Iwata NK; Goto J; Nakashima R; Mimori T; Toda T Neuromuscul Disord; 2022 Jan; 32(1):25-32. PubMed ID: 34916121 [TBL] [Abstract][Full Text] [Related]
49. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China. Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933 [TBL] [Abstract][Full Text] [Related]
50. [A case of anti-SRP antibody-positive immune-mediated necrotizing myopathy triggered by human parvovirus B19 infection]. Suzuki I; Nakao R; Unai Y; Miyazaki Y Rinsho Shinkeigaku; 2022 May; 62(5):363-368. PubMed ID: 35474284 [TBL] [Abstract][Full Text] [Related]
51. [A case of amyloid myopathy diagnosed during the treatment of myopathy associated with anti-signal recognition particle antibodies]. Kawakami N; Katsuyama Y; Hagiwara Y; Yoshida H; Kim K; Harada K Rinsho Shinkeigaku; 2017 Apr; 57(4):168-173. PubMed ID: 28367947 [TBL] [Abstract][Full Text] [Related]
52. Initial seronegative immune-mediated necrotising myopathy with subsequent anti-HMGCR antibody development and response to rituximab: case report. Thomas R; Yeoh SA; Berkeley R; Woods A; Stevens M; Marino S; Radunovic A BMC Rheumatol; 2020; 4():29. PubMed ID: 32613157 [TBL] [Abstract][Full Text] [Related]
53. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed. Carvalho AAS; Silva VGD; Vieira TF; Delgado PO; Corazini R; Feder D; Fonseca FLA Medicine (Baltimore); 2018 Aug; 97(35):e11858. PubMed ID: 30170376 [TBL] [Abstract][Full Text] [Related]